DUBLIN--(BUSINESS WIRE)--The "Global Next Generation Sequencing (NGS) Market - Segmented by Sequencing Type, Product, End User, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The global next generation sequencing market is expected to register a CAGR of 19.5% during 2018 to 2023 (the forecast period).
The increasing applications in clinical diagnosis is one the major factors responsible for the growth of this market. In the recent years, technologies, such as Illumina/Solexa, ABI/SOLiD, 454/Roche, and Helicos, have provided unique prospects for high-throughput functional genomic research. Its applications in the diagnosis includes a variety of illnesses, such as cancer, hematological disorders, neurology, psychiatry, dysmorphology, vision and hearing impairment, cardiology, and pharmacogenomics.
Other factors, such as the speed, cost and accuracy of NGS, efficient replacement for traditional technologies like microarrays, and rise in drug discovery applications demanding NGS technology, are also contributing to the growth of the next-generation sequencing market.
Ethical and legal discussions have always been part of medical research. Funding agencies and journals often submit genomic data from research participants to their databases - this allows investigators to control data. Giving such access, risks the identity of the individuals or families. The data and samples are sent from the databases without the consent of the participant, putting them at risk. The unidirectional flow of data out of the system creates a sense of exploitation and distrust. Therefore, the legal and ethical issues hinder the growth of the next-generation sequencing market.
Companies Mentioned
- Agilent Technologies
- Dnastar Inc.
- F. Hoffmann-La Roche Ltd
- Gatc Biotech Ag
- Illumina Inc.
- Macrogen Inc.
- Pacific Biosciences Of California Inc.
- Perkinelmer Inc.
- Qiagen
- Thermo Fisher Scientific Inc.
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/tk39s9/global_next?w=4